Loading…

P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV‐SPECIFIC T‐CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE

Saved in:
Bibliographic Details
Published in:HemaSphere 2023-08, Vol.7 (S3), p.e8073255-n/a
Main Authors: Choquet, Sylvain, Clark, Andrew, Renard, Cécile, Uttenthal, Ben, Chaganti, Sridhar, Ulrich Trappe, Ralf, Comoli, Patrizia, Duan, Xinyuan, Xing, Baodong, Wu, Charley, Gamelin, Laurence, Terwey, Jan‐Henrik, Friedetzky, Anke, Dierickx, Daan
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000972440.80732.55